Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

被引：0
|
作者：
Yuqi Jiang
Jing Wang
Peng Jiang
Xiang Wang
Lei Zhang
Yongchun Zhang
机构：
[1] The Affiliated Hospital of Qingdao University,Department of Radiation Oncology
来源：
BMC Cancer | / 23卷
关键词：
Uterine cervical neoplasms; Neoplasm recurrence; Intensity modulated radiotherapy; Adverse effects; Simultaneous integrated boost intensity-modulated radiotherapy; High-risk CTV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma Clinical outcomes and patterns of failure in an endemic area in China
    Zeng, Lei
    Tian, Yun-Ming
    Sun, Xue-Ming
    Huang, Ying
    Chen, Chun-Yan
    Han, Fei
    Liu, Shuai
    Lan, Mei
    Guan, Ying
    Deng, Xiao-Wu
    Lu, Tai-Xiang
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (11) : 993 - 1000
  • [22] Treatment of High-Risk Gastric Cancer Postoperatively Using Intensity-Modulated Radiotherapy: A Single-Institution Experience
    Li, Pu
    Sheny, Li-Ming
    Deng, Qing-Hua
    Zhu, Yuan
    Liu, Lu-Ying
    Liu, Peng
    Lu, Ke
    HEPATO-GASTROENTEROLOGY, 2012, 59 (113) : 159 - 163
  • [23] ACUTE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN SUPPRESSION AND HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY
    Pervez, Nadeem
    Small, Cormac
    MacKenzie, Marc
    Yee, Don
    Parliament, Matthew
    Ghosh, Sunita
    Mihai, Alina
    Amanie, John
    Murtha, Albert
    Field, Colin
    Murray, David
    Fallone, Gino
    Pearcey, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 57 - 64
  • [24] Intensity-modulated radiotherapy with sentinel-node-based target volume optimisation in "high-risk" prostate cancer
    Ganswindt, U
    Paulsen, F
    Glocker, S
    Birkner, M
    Alber, M
    Corvin, S
    Anastasiadis, A
    Eichhorn, K
    Bares, R
    Stenzl, A
    Bamberg, M
    Belka, C
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 4 - 4
  • [25] EFFECT OF INTENSITY-MODULATED PELVIC RADIOTHERAPY ON SECOND CANCER RISK IN THE POSTOPERATIVE TREATMENT OF ENDOMETRIAL AND CERVICAL CANCER
    Zwahlen, Daniel R.
    Rad, Jeremy D. Ruben F. C.
    Jones, Phillip
    Gagliardi, Frank
    Millar, Jeremy L.
    Schneider, Uwe
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 539 - 545
  • [26] Intensity-modulated radiotherapy with sentinel-node-based target volume optimisation in "high-risk" prostate cancer - first clinical experiences
    Ganswindt, U.
    Paulsen, F.
    Alber, M.
    Corvin, S.
    Bares, R.
    Hundt, I
    Stenzl, A.
    Bamberg, M.
    Belka, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 78 - 78
  • [27] The effect of dose-painted intensity-modulated radiotherapy combined with chemotherapy for stage IIIB cervical cancer
    Liu, Yunqin
    Zang, Chunbao
    Qian, Liting
    Wu, Ailin
    Ke, Xue
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 2813 - 2821
  • [28] A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer
    Qiao, Lili
    Cheng, Jian
    Liang, Ning
    Xie, Jian
    Luo, Hui
    Zhang, Jiandong
    ONCOLOGY LETTERS, 2016, 11 (02) : 959 - 964
  • [29] ROLE OF INTENSITY MODULATED RADIOTHERAPY IN POSTOPERATIVE INTERMEDIATE AND HIGH RISK CERVICAL CANCER
    Patel, P.
    Vyas, R.
    Mehta, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 598 - 598
  • [30] Intensity-modulated Radiotherapy (80 Gy) in Low, Intermediate, and High-risk Prostate Cancer: Factors Influencing Relapse and Toxicity
    Charissoux, M.
    Moscardo, C. Llacer
    Thezenas, S.
    Fenoglietto, P.
    Ailleres, N.
    Segui, B.
    Rebillard, X.
    Hay, M.
    Dubois, J.
    Azria, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S642 - S642
12345